MedTrace Logo

Assessing Opioid Care Practices Using CPV Patient Simulation Modules

NCT04080037 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2020-02-10

No results posted yet for this study

Summary

This study will test the quality of opioid-related physician care decisions using a patient-simulation based measurement and feedback approach that combines multiple-choice care decisions with real-time, personalized scoring and feedback. The cases and feedback have been designed to align with the latest CDC opioid guidelines. The study will also measure the impact of gaming-inspired competition and motivation, including a weekly leaderboard, to improve evidence-based care decisions. The quality of care decisions will be measured in the simulations and in a multiple-choice assessment administered before and after the patient simulations.

Conditions

  • Pain
  • Pain, Acute
  • Pain, Chronic
  • Pain, Neuropathic
  • Opioid-use Disorder
  • Opioid Abuse and Addiction
  • Opioid Withdrawal

Interventions

OTHER

Quality IQ Patient Simulations

Online patient cases designed to simulate typical patients seen in a primary care practice. In each case, providers will answer multiple-choice questions about their preferred course of action to work-up, diagnose and treat patients in the primary care setting. After each question, providers will receive evidence-based feedback, including references, on the appropriateness of each of their care decisions. Feedback will be supported with relevant reference to evidence-based guidelines, with a specific focus on the CDC opioid guidelines. Cases will cover typical primary care patients presenting with acute and chronic pain, who may or may not be already taking opioid medication.

Sponsors & Collaborators

  • Ascend Learning

    collaborator UNKNOWN

  • Qure Healthcare, LLC

    lead INDUSTRY

Principal Investigators

  • John Peabody, MD, PhD · QURE Healthcare

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-03
Primary Completion
2019-10-29
Completion
2019-10-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04080037 on ClinicalTrials.gov